close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Gesloten

SectorGezondheidszorg

8.9 3.85

Strong Buy

Prijsupdate 20 apr 2026, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.22

Max

8.95

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+74.22% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

30M

187M

Vorige openingsprijs

5.05

Vorige sluitingsprijs

8.9

Nieuwssentiment

By Acuity

25%

75%

83 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 apr 2026, 23:49 UTC

Belangrijke Nieuwsgebeurtenissen

New Zealand 1Q Inflation Higher Than Expected

DJ

Lezen

20 apr 2026, 23:10 UTC

Populaire aandelen

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

DJ

Lezen

20 apr 2026, 22:53 UTC

Belangrijke Marktbewegers

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

DJ

Lezen

20 apr 2026, 23:45 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

DJ

Lezen

20 apr 2026, 23:44 UTC

Marktinformatie

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

DJ

Lezen

20 apr 2026, 23:39 UTC

Marktinformatie

Rio Tinto Posts Strong Start to Year -- Market Talk

DJ

Lezen

20 apr 2026, 23:30 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

20 apr 2026, 23:30 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

20 apr 2026, 23:30 UTC

Marktinformatie

Super Retail's Earnings Outlook Less Rosy -- Market Talk

DJ

Lezen

20 apr 2026, 23:09 UTC

Marktinformatie

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

DJ

Lezen

20 apr 2026, 22:31 UTC

Acquisities, Fusies, Overnames

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

DJ

Lezen

20 apr 2026, 22:26 UTC

Acquisities, Fusies, Overnames

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

DJ

Lezen

20 apr 2026, 22:25 UTC

Acquisities, Fusies, Overnames

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

DJ

Lezen

20 apr 2026, 22:25 UTC

Acquisities, Fusies, Overnames

West African Resources Aims for Acquisition to Be Completed by End-2026

DJ

Lezen

20 apr 2026, 22:25 UTC

Acquisities, Fusies, Overnames

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

DJ

Lezen

20 apr 2026, 22:25 UTC

Acquisities, Fusies, Overnames

West African Resources Says Acquisition Would Be for A$175 Million

DJ

Lezen

20 apr 2026, 22:24 UTC

Acquisities, Fusies, Overnames

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

DJ

Lezen

20 apr 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

DJ

Lezen

20 apr 2026, 22:01 UTC

Acquisities, Fusies, Overnames

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

DJ

Lezen

20 apr 2026, 21:38 UTC

Marktinformatie

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

DJ

Lezen

20 apr 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

DJ

Lezen

20 apr 2026, 21:24 UTC

Marktinformatie

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

DJ

Lezen

20 apr 2026, 21:24 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

20 apr 2026, 21:13 UTC

Winsten

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

DJ

Lezen

20 apr 2026, 21:10 UTC

Winsten

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

DJ

Lezen

20 apr 2026, 21:09 UTC

Winsten

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

DJ

Lezen

20 apr 2026, 21:08 UTC

Winsten

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

DJ

Lezen

20 apr 2026, 21:07 UTC

Winsten

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

DJ

Lezen

20 apr 2026, 21:05 UTC

Winsten

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

DJ

Lezen

20 apr 2026, 21:05 UTC

Winsten

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

74.22% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15 USD  74.22%

Hoogste 28 USD

Laagste 8 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

83 / 348 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

85.26

↓-0.95%

A

Agilent Technologies Inc

120.85

↓-0.66%

VEEV

Veeva Systems Inc

168.97

↑ +0.64%

HQY

HealthEquity Inc

86.11

↑ +0.21%

NEOG

Neogen Corp

9.63

↑ +1.37%
help-icon Live chat